Report Detail

Other Global Dermatophytic Onychomycosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2570433
  • |
  • 19 November, 2018
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Table of Contents

    1 Dermatophytic Onychomycosis Treatment Market Overview

    • 1.1 Product Overview and Scope of Dermatophytic Onychomycosis Treatment
    • 1.2 Classification of Dermatophytic Onychomycosis Treatment by Types
      • 1.2.1 Global Dermatophytic Onychomycosis Treatment Revenue Comparison by Types (2017-2023)
      • 1.2.2 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Types in 2017
      • 1.2.3 Systemic Therapy
      • 1.2.4 Topical Therapy
      • 1.2.5 Other
    • 1.3 Global Dermatophytic Onychomycosis Treatment Market by Application
      • 1.3.1 Global Dermatophytic Onychomycosis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
      • 1.3.2 Hospitals
      • 1.3.3 Dermatology Clinics
      • 1.3.4 Other
    • 1.4 Global Dermatophytic Onychomycosis Treatment Market by Regions
      • 1.4.1 Global Dermatophytic Onychomycosis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
      • 1.4.1 North America (USA, Canada and Mexico) Dermatophytic Onychomycosis Treatment Status and Prospect (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Dermatophytic Onychomycosis Treatment Status and Prospect (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dermatophytic Onychomycosis Treatment Status and Prospect (2013-2023)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Dermatophytic Onychomycosis Treatment Status and Prospect (2013-2023)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dermatophytic Onychomycosis Treatment Status and Prospect (2013-2023)
    • 1.5 Global Market Size of Dermatophytic Onychomycosis Treatment (2013-2023)

    2 Manufacturers Profiles

    • 2.1 Bausch Health Companies
      • 2.1.1 Business Overview
      • 2.1.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bausch Health Companies Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Novartis AG
      • 2.2.1 Business Overview
      • 2.2.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis AG Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Johnson and Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson and Johnson Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Galderma S.A.
      • 2.4.1 Business Overview
      • 2.4.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Galderma S.A. Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Celtic Pharmaceuticals
      • 2.5.1 Business Overview
      • 2.5.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Anacor Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Moberg Pharma AB
      • 2.7.1 Business Overview
      • 2.7.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Moberg Pharma AB Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 GlaxoSmithKline
      • 2.8.1 Business Overview
      • 2.8.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 GlaxoSmithKline Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Pfizer Inc
      • 2.9.1 Business Overview
      • 2.9.2 Dermatophytic Onychomycosis Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Pfizer Inc Dermatophytic Onychomycosis Treatment Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Dermatophytic Onychomycosis Treatment Market Competition, by Players

    • 3.1 Global Dermatophytic Onychomycosis Treatment Revenue and Share by Players (2013-2018)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Dermatophytic Onychomycosis Treatment Players Market Share
      • 3.2.2 Top 10 Dermatophytic Onychomycosis Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Dermatophytic Onychomycosis Treatment Market Size by Regions

    • 4.1 Global Dermatophytic Onychomycosis Treatment Revenue and Market Share by Regions
    • 4.2 North America Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 4.3 Europe Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 4.5 South America Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    5 North America Dermatophytic Onychomycosis Treatment Revenue by Countries

    • 5.1 North America Dermatophytic Onychomycosis Treatment Revenue by Countries (2013-2018)
    • 5.2 USA Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 5.3 Canada Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 5.4 Mexico Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    6 Europe Dermatophytic Onychomycosis Treatment Revenue by Countries

    • 6.1 Europe Dermatophytic Onychomycosis Treatment Revenue by Countries (2013-2018)
    • 6.2 Germany Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 6.3 UK Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 6.4 France Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 6.5 Russia Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 6.6 Italy Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    7 Asia-Pacific Dermatophytic Onychomycosis Treatment Revenue by Countries

    • 7.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Revenue by Countries (2013-2018)
    • 7.2 China Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 7.3 Japan Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 7.4 Korea Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 7.5 India Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    8 South America Dermatophytic Onychomycosis Treatment Revenue by Countries

    • 8.1 South America Dermatophytic Onychomycosis Treatment Revenue by Countries (2013-2018)
    • 8.2 Brazil Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 8.3 Argentina Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 8.4 Colombia Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    9 Middle East and Africa Revenue Dermatophytic Onychomycosis Treatment by Countries

    • 9.1 Middle East and Africa Dermatophytic Onychomycosis Treatment Revenue by Countries (2013-2018)
    • 9.2 Saudi Arabia Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 9.3 UAE Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 9.4 Egypt Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 9.5 Nigeria Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)
    • 9.6 South Africa Dermatophytic Onychomycosis Treatment Revenue and Growth Rate (2013-2018)

    10 Global Dermatophytic Onychomycosis Treatment Market Segment by Type

    • 10.1 Global Dermatophytic Onychomycosis Treatment Revenue and Market Share by Type (2013-2018)
    • 10.2 Global Dermatophytic Onychomycosis Treatment Market Forecast by Type (2018-2023)
    • 10.3 Systemic Therapy Revenue Growth Rate (2013-2023)
    • 10.4 Topical Therapy Revenue Growth Rate (2013-2023)
    • 10.5 Other Revenue Growth Rate (2013-2023)

    11 Global Dermatophytic Onychomycosis Treatment Market Segment by Application

    • 11.1 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2013-2018)
    • 11.2 Dermatophytic Onychomycosis Treatment Market Forecast by Application (2018-2023)
    • 11.3 Hospitals Revenue Growth (2013-2018)
    • 11.4 Dermatology Clinics Revenue Growth (2013-2018)
    • 11.5 Other Revenue Growth (2013-2018)

    12 Global Dermatophytic Onychomycosis Treatment Market Size Forecast (2018-2023)

    • 12.1 Global Dermatophytic Onychomycosis Treatment Market Size Forecast (2018-2023)
    • 12.2 Global Dermatophytic Onychomycosis Treatment Market Forecast by Regions (2018-2023)
    • 12.3 North America Dermatophytic Onychomycosis Treatment Revenue Market Forecast (2018-2023)
    • 12.4 Europe Dermatophytic Onychomycosis Treatment Revenue Market Forecast (2018-2023)
    • 12.5 Asia-Pacific Dermatophytic Onychomycosis Treatment Revenue Market Forecast (2018-2023)
    • 12.6 South America Dermatophytic Onychomycosis Treatment Revenue Market Forecast (2018-2023)
    • 12.7 Middle East and Africa Dermatophytic Onychomycosis Treatment Revenue Market Forecast (2018-2023)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.

      Scope of the Report:
      Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.
      The global Dermatophytic Onychomycosis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dermatophytic Onychomycosis Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
      This report studies the Dermatophytic Onychomycosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dermatophytic Onychomycosis Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Bausch Health Companies
      Novartis AG
      Johnson and Johnson
      Galderma S.A.
      Celtic Pharmaceuticals
      Anacor Pharmaceuticals
      Moberg Pharma AB
      GlaxoSmithKline
      Pfizer Inc

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Systemic Therapy
      Topical Therapy
      Other

      Market Segment by Applications, can be divided into
      Hospitals
      Dermatology Clinics
      Other


      Summary:
      Get latest Market Research Reports on Dermatophytic Onychomycosis Treatment . Industry analysis & Market Report on Dermatophytic Onychomycosis Treatment is a syndicated market report, published as Global Dermatophytic Onychomycosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Dermatophytic Onychomycosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,578.68
      3,868.02
      5,157.36
      3,076.32
      4,614.48
      6,152.64
      396,163.20
      594,244.80
      792,326.40
      259,677.60
      389,516.40
      519,355.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report